IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
0.784
-0.036 (-4.57%)
Nov 21, 2024, 3:02 PM EST - Market open
IO Biotech Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 80.19 | 143.19 | 142.59 | 211.53 | 3.41 | 7.85 |
Cash & Short-Term Investments | 80.19 | 143.19 | 142.59 | 211.53 | 3.41 | 7.85 |
Cash Growth | -51.55% | 0.42% | -32.59% | 6112.36% | -56.60% | - |
Other Receivables | - | 1.13 | 1.53 | 2.09 | 1.5 | 1.23 |
Receivables | - | 1.13 | 1.53 | 2.09 | 1.5 | 1.23 |
Prepaid Expenses | 6.06 | 1.35 | 1.72 | 3.2 | - | - |
Other Current Assets | - | 1.58 | 2.38 | 4.92 | 0.73 | 0.32 |
Total Current Assets | 86.24 | 147.26 | 148.22 | 221.74 | 5.64 | 9.4 |
Property, Plant & Equipment | 2.51 | 3.11 | 3.23 | 0.16 | - | - |
Other Long-Term Assets | 1.19 | 0.36 | 0.35 | 0.4 | 0.02 | 0.02 |
Total Assets | 89.95 | 150.72 | 151.81 | 222.29 | 5.65 | 9.42 |
Accounts Payable | 5.26 | 3.88 | 4 | 3.93 | 0.52 | 1 |
Accrued Expenses | 10.11 | 10.62 | 4.21 | 5.92 | 2.27 | 0.95 |
Short-Term Debt | - | - | - | - | - | 8.66 |
Current Portion of Leases | 0.69 | 0.66 | 0.52 | - | - | - |
Other Current Liabilities | - | 0.56 | 1.95 | 0.46 | 0.26 | 0.23 |
Total Current Liabilities | 16.06 | 15.72 | 10.68 | 10.31 | 3.05 | 10.84 |
Long-Term Leases | 1.33 | 1.84 | 2.28 | - | - | - |
Other Long-Term Liabilities | - | - | - | 0.06 | - | 0.05 |
Total Liabilities | 17.38 | 17.56 | 12.95 | 10.36 | 3.05 | 10.89 |
Common Stock | 0.07 | 0.07 | 0.03 | 0.03 | 0.03 | 0.01 |
Additional Paid-In Capital | 411.48 | 406.59 | 326.71 | 319.67 | 1.11 | 1.52 |
Retained Earnings | -327.98 | -263.82 | -177.74 | -106.28 | -38.4 | -26.36 |
Comprehensive Income & Other | -11 | -9.67 | -10.14 | -1.49 | 1.96 | 1.3 |
Total Common Equity | 72.57 | 133.16 | 138.85 | 211.92 | -35.3 | -23.53 |
Shareholders' Equity | 72.57 | 133.16 | 138.85 | 211.92 | 2.6 | -1.47 |
Total Liabilities & Equity | 89.95 | 150.72 | 151.81 | 222.29 | 5.65 | 9.42 |
Total Debt | 2.02 | 2.49 | 2.79 | - | - | 8.66 |
Net Cash (Debt) | 78.17 | 140.7 | 139.8 | 211.53 | 3.41 | -0.82 |
Net Cash Growth | -52.02% | 0.64% | -33.91% | 6112.36% | - | - |
Net Cash Per Share | 1.19 | 3.23 | 4.85 | 48.79 | 19.22 | -4.61 |
Filing Date Shares Outstanding | 65.88 | 65.88 | 28.82 | 28.82 | 0.18 | 0.18 |
Total Common Shares Outstanding | 65.88 | 65.88 | 28.82 | 28.82 | 0.18 | 0.18 |
Working Capital | 70.19 | 131.54 | 137.54 | 211.43 | 2.59 | -1.44 |
Book Value Per Share | 1.10 | 2.02 | 4.82 | 7.35 | -199.23 | -132.79 |
Tangible Book Value | 72.57 | 133.16 | 138.85 | 211.92 | -35.3 | -23.53 |
Tangible Book Value Per Share | 1.10 | 2.02 | 4.82 | 7.35 | -199.23 | -132.79 |
Machinery | - | 1.18 | 0.86 | 0.17 | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.